Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how well Rituximab works in early stages of disease
and the effects it has on an inflamed joint and blood cells.
This will allow the investigators to get a better understanding of how this treatment affects
the inflamed joints of rheumatoid arthritis (RA) patients.